The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $127.01

Today's change-0.34 -0.27%
Updated August 4 4:03 PM EDT. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $127.01

Today's change-0.34 -0.27%
Updated August 4 4:03 PM EDT. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings down (U.S.)$0.34

Laboratory Corporation of America Holdings closed lower Tuesday, dropping (U.S.)$0.34 or 0.27% to (U.S.)$127.01. Over the last five days, shares have gained 3.93% and are currently 3.19% off of the 52-week high. Shares have outperformed the S&P 500 by 14.04% during the last year.

Key company metrics

  • Open(U.S.) $127.47
  • Previous close(U.S.) $127.35
  • High(U.S.) $127.78
  • Low(U.S.) $126.62
  • Bid / Ask(U.S.) $123.83 / (U.S.) $133.39
  • YTD % change+17.71%
  • Volume868,678
  • Average volume (10-day)1,226,792
  • Average volume (1-month)1,067,542
  • Average volume (3-month)1,132,581
  • 52-week range(U.S.) $95.61 to (U.S.) $131.19
  • Beta0.73
  • Trailing P/E27.43×
  • P/E 1 year forward16.19×
  • Forward PEG1.45×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.63
Updated August 4 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.00%

Based on its net profit margin of 6.00%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.16%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue2,2691,7931,5131,552
Total other revenue--------
Total revenue2,2691,7931,5131,552
Gross profit775623547571
Total cost of revenue1,4951,170966981
Total operating expense1,9481,6621,2941,310
Selling / general / administrative392440310306
Research & development--------
Depreciation / amortization47321518
Interest expense (income), net operating--------
Unusual expense (income)141926
Other operating expenses, total--------
Operating income321131219241
Interest income (expense), net non-operating-58-104-32-26
Gain (loss) on sale of assets--------
Other--------
Income before tax26431188219
Income after tax1692120138
Income tax, total96306882
Net income1681120137
Total adjustments to net income--------
Net income before extra. items1681120137
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1681120137
Inc. avail. to common incl. extra. items1681120137
Diluted net income1682120137
Dilution adjustment--00--
Diluted weighted average shares1031008687
Diluted EPS excluding extraordinary itemsvalue per share1.640.021.391.59
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share1.730.141.401.63